Related Experiment Video
Updated: Feb 26, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Prevalence, factors influencing and knowledge about adherence to lipid-lowering therapy among hyperlipidemia patients
N K Devaraj1, M Mohamed2, N Hussein2
1Universiti Putra Malaysia, Department of Family Medicine, 43400,Serdang, Selangor, Malaysia. knavin@upm.edu.my.
Insights
High adherence to lipid-lowering therapy was observed in Malaysian patients with hyperlipidemia. Interventions should focus on identified non-adherent individuals to improve cardiovascular disease risk management.
Area of Science:
- Cardiology
- Public Health
- Pharmacoeconomics
Background:
- Hyperlipidemia is a major risk factor for cardiovascular disease.
- Adherence to lipid-lowering therapy is often suboptimal.
- Patient, therapy, socio-economic, and health system factors influence adherence.
Purpose of the Study:
- To determine the prevalence of adherence to lipid-lowering therapy.
- To identify factors contributing to non-adherence.
- To assess knowledge of hyperlipidemia and its treatment among Malaysian patients.
Main Methods:
- A cross-sectional survey was conducted in an urban primary care clinic.
- Simple random sampling selected patients on lipid-lowering therapy for ≥ 1 year.
- A self-administered questionnaire assessed adherence, reasons for non-adherence, and knowledge.
Main Results:
- The adherence rate was 82.4% with a 90.7% response rate.
- Common reasons for non-adherence included fear of side effects, polypharmacy, and external influences.
- Non-adherence was associated with male gender, longer therapy duration, fewer follow-ups, and lower knowledge scores.
Conclusions:
- The prevalence of adherence to lipid-lowering therapy was high among Malaysian hyperlipidemia patients.
- Targeted interventions are needed for non-adherent patients to enhance treatment outcomes.
Background:
Hyperlipidaemia is a significant risk factor for cardiovascular disease. However, adherence to lipidlowering therapy is often unsatisfactory due to a combination of patient factors, therapy, socio-economic and health system-related factors.
Aims:
to identify the prevalence of adherence to lipidlowering therapy, the factors contributing to non-adherence and knowledge regarding hyperlipidaemia and its' treatment among Malaysian patients with hyperlipidemia.
Methods:
A quantitative study using a cross-sectional survey was carried out in an urban primary care clinic in August 2015. Patients on lipid-lowering therapy for ≥ 1 year aged ≥ 18 years were selected using simple random sampling. consenting patients answered a selfadministered questionnaire (in Malay/English) which included socio-demographic profile, hyperlipidaemia profile, adherence to lipid-lowering therapy (using the Morisky Medication Adherence scale-8; score ≥ 6 taken as adherent), reasons leading to non-adherence, knowledge regarding hyperlipidaemia and its' treatment, and use of non-allopathic medicine.
Results:
the response rate was 90.7%. the prevalence of adherence to lipid-lowering therapy was 82.4%. "the most common reasons for non-adherence was being worried about side effect of lipid-lowering agent (71.4%), followed by the need to take too many drugs in a day (61.4%) and negative influences by friends, relative and mass media (60%)". Factors associated with non-adherence include male gender, on longer duration of therapy, less frequency of follow-up, less number of follow-up clinics, taking medication at night/random timing and having lower knowledge scores.
Conclusion:
Overall the prevalence of adherence was high in patients with hyperlipidaemia. Interventions to boost adherence should target those who were identified as nonadherent.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
